Top Buy
| Security | Buy | Sell ▲ | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Twist Bioscience Corp | 7 | 0 | 3 | 0 | €38.94 | €41.41 | 6.341% |
| Cocrystal Pharma Inc. | 7 | 0 | 1 | 0 | €2.18 | €9.25 | 324.495% |
| Medpace Holdings Inc | 9 | 0 | 0 | 0 | €364.00 | €421.61 | 15.826% |
| Blueprint Medicines Corp | 2 | 0 | 1 | 0 | €93.68 | - | - |
| Intra-Cellular Therapies Inc. | 25 | 0 | 2 | 0 | €60.50 | €79.55 | 31.495% |
| Sutro Biopharma Inc | 21 | 0 | 3 | 0 | €3.82 | €11.04 | 189.068% |
| Agios Pharmaceuticals Inc. | 6 | 0 | 1 | 0 | €31.40 | €38.99 | 24.168% |
| Vericel Corp. | 1 | 0 | 0 | 0 | €44.20 | - | - |
| Vanda Pharmaceuticals | 4 | 0 | 0 | 0 | €4.82 | €5.00 | 3.734% |
| Evolus Inc | 10 | 0 | 4 | 0 | €11.10 | €20.46 | 84.344% |
| Amgen Inc. | 25 | 0 | 4 | 0 | €280.85 | €297.31 | 5.861% |
| Deciphera Pharmaceuticals | 6 | 0 | 0 | 0 | €23.20 | €21.66 | -6.642% |
| Geron Corp. | 12 | 0 | 2 | 0 | €3.21 | €4.63 | 44.106% |
| MannKind Corp. | 8 | 0 | 1 | 0 | €4.39 | €6.03 | 37.269% |
| Charles River Labs Intl | 10 | 0 | 1 | 0 | €200.40 | €248.57 | 24.037% |
| Exelixis Inc. | 18 | 0 | 3 | 0 | €18.58 | €26.01 | 40.008% |
| Anika Therapeutics | 5 | 0 | 1 | 0 | €22.60 | €28.29 | 25.180% |
| Corcept Therapeutics Inc. | 11 | 0 | 2 | 0 | €25.84 | €35.43 | 37.110% |
| Neurocrine Bioscience | 29 | 0 | 6 | 0 | €127.60 | €140.60 | 10.191% |
| Brainstorm Cell | 1 | 0 | 0 | 0 | €0.50 | - | - |
| Halozyme Therapeutics Inc. | 15 | 0 | 3 | 0 | €40.40 | €47.17 | 16.757% |
| SCYNEXIS Inc. | 5 | 0 | 0 | 0 | €2.16 | €8.35 | 287.062% |
| Immunogen Inc. | 5 | 0 | 0 | 0 | €28.97 | - | - |
| Ardelyx Inc. | 2 | 0 | 0 | 0 | €6.47 | €11.00 | 70.068% |
| Rigel Pharmaceutical Inc. | 10 | 0 | 1 | 0 | €0.84 | €13.77 | 1548.474% |